论文信息 - Abstract 5454: Amdizalisib (HMPL-689), a highly selective PI3Kδ inhibitor, exhibits potent anti-tumor activity in pre-clinical B-cell lymphoma models - 字舞流文

Abstract 5454: Amdizalisib (HMPL-689), a highly selective PI3Kδ inhibitor, exhibits potent anti-tumor activity in pre-clinical B-cell lymphoma models

Weiguo Qing | Xiong Li | Juntao Yu | W. Su | Yongxin Ren | Jia Hu | X. Dai | Na Yang | Linfang Wang | Junqing Liang | Jianlin He | Yu Cai | Ying Yu | Jianhang Wang